Trial Profile
Febuxostat for Allopurinol-Refractory Hyperuricemia in Gout Treatment of Dialysis Patients or Those in Stage 4 Chronic Kidney Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- 27 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.